We and others have previously highlighted the association between CMS4, high levels of cancer-associated fibroblasts (CAFs), and poor prognosis in CRC [22–25] Therefore, we next set out to delineate the cellular-specific source of GREM1 from within the TME of stromal-rich CMS4 tumours. This evidence concerns the gene GREM1 and colorectal carcinoma.